CytoMed Therapeutics
GDTC
GDTC
2 hedge funds and large institutions have $20.7K invested in CytoMed Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SSG
Summit Securities Group
New York
|
+$19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.48K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SSG
1
Summit Securities Group
New York
| $19K | +$19K | +5,407 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.67K | +$1.48K | +423 | +783% |
|